Skip to content

VM Pharma

Active Private limited companyfounded 2020active for 6 yearsThéophile Vander Elststraat 42, 1170 Watermael-BoitsfortKBO/BCE: BE 0743.948.725

Lifetime

6 annual accounts with figures on one time axis
peak of €213,180 in 2022
€131,435▼ 24.8%
lowest -€17,906 in 2025
-€17,906▼ €32,892
peak of €260,457 in 2024
€242,551▼ 6.9%
€286,174▲ 117%
Board1 name since 2020
1 director
Documentsfilings and deeds
04-08-20264 days late
2025micro format
Gross margin from €174,740 to €131,435Loss of €17,906Debts from €131,987 to €286,174Cash from €9,415 to €54,967

Key points

from the 2025 annual accounts

Turnover

≈ €460,000 estimated

The micro format states no turnover.

Debts

€286,174 ▲ 117%
Suppliers
+139,802
Other debts
+34,235
The rest
-19,850

Debts rose by €154,187 in 2025.

Liquidity

1.77 was 3.87 in 2024

Short-term debts rose from €70,632 to €243,609.

Filings

6 annual accounts 2 late
AprilJune31 JulyOctober202020222024

The 2020 accounts came in latest, 27 days after the end of the period.

Position in the sector

-€17,906

Lower net result than 87% of companies in retail trade. The sector median is €4,726, over 25,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 930 companies had the same profile as VM Pharma has now. Each dot stands for 3 companies, two years later.

92.7%
were still trading
5.5%
stopped another way
1.7%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a small loss

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 930 companies, not a prediction for VM Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 25-02-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0743948725
Incorporation Founding capital of €50,000, 100 shares · Founded by · appointed as director · published on 25-02-2020 · Gazette deed
All 13 events

Comparable companies

same main activity, similar in size and age
Company
VM Pharma Watermael-Boitsfort €528,725 €131,435 45.9% -
PHARMACIE MONT-A-LEUX Ypres €508,078 €147,618 19.5% -
Apotheek De Arend Antwerp €483,989 €145,662 3.4% -
APOTHEEK VOSSELARE Deinze €563,733 €138,106 22.7% 0
Axepharma Beernem €442,129 €151,840 70.1% 1.1
De Maeyer Groot-Bijgaarden Dilbeek €479,884 €163,151 37.3% 1
DURAN ZEHRA Ghent €531,335 €165,010 50.6% -

These companies have the same main activity as VM Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €442,000 and €564,000, founded between 2018 and 2020.

Official details

Source: KBO
Status
Active since 21-02-2020Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.300.319.6631170 Watermael-Boitsfort, since 21-02-2020
Financial year end
31 December
Peppol
Reachable since 23-09-2025
Company details

Annual accounts 2025

€528,725▲ 34.7%
Filing
Filed on 04-08-2026
Financials

Insights on VM Pharma

VM Pharma files the micro format. That format states no turnover. The gross margin rose from €69,706 in 2020 to €131,435 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about VM Pharma

What is the company number of VM Pharma?
The company number of VM Pharma is 0743.948.725. The VAT number is the same number with BE in front: BE 0743.948.725.
Where is VM Pharma based?
The registered office is at Théophile Vander Elststraat 42, 1170 Watermael-Boitsfort.Company details
What does VM Pharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of VM Pharma?
VM Pharma is a private limited company (BV).
When was VM Pharma founded?
VM Pharma was founded on 21-02-2020.
Is VM Pharma still active?
Yes, VM Pharma is an active enterprise in the KBO register.
What is the turnover of VM Pharma?
The turnover in financial year 2025 is about €460,000. This figure is estimated from the gross margin of €131,435 and 37 comparable companies (NACE 477). It probably lies between €350,000 and €780,000.Financials
Is VM Pharma profitable?
In financial year 2025, VM Pharma made a loss of €17,906.
Where can I find the annual accounts of VM Pharma?
VM Pharma filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VM Pharma due?
VM Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.